Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |